Latest news from University of Texas MD Anderson Cancer Center on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/esmo-combination-therapy-reduced-agitated-delirium-in-patients-with-advanced-cancers/?sc=rsin /articles/esmo-combination-therapy-reduced-agitated-delirium-in-patients-with-advanced-cancers/?sc=rsin Sat, 14 Sep 2024 09:45:00 EST Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with advanced cancers, compared with haloperidol alone, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center. University of Texas MD Anderson Cancer Center /articles/esmo-novel-adc-azd8205-demonstrates-manageable-safety-profile-and-preliminary-efficacy-in-first-in-human-trial/?sc=rsin /articles/esmo-novel-adc-azd8205-demonstrates-manageable-safety-profile-and-preliminary-efficacy-in-first-in-human-trial/?sc=rsin Fri, 13 Sep 2024 09:05:13 EST The antibody-drug conjugate (ADC) puxitatug samrotecan (AZD8205) demonstrated a manageable safety profile consistent with similar ADCs and initial efficacy in heavily pretreated patients with advanced or metastatic solid tumors, according to interim data shared today at the 2024 European Society for Medical Oncology (ESMO) Congress by researchers from The University of Texas MD Anderson Cancer Center. University of Texas MD Anderson Cancer Center /articles/md-anderson-research-highlights-special-edition-esmo-2024/?sc=rsin /articles/md-anderson-research-highlights-special-edition-esmo-2024/?sc=rsin Tue, 10 Sep 2024 10:00:01 EST The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. University of Texas MD Anderson Cancer Center /articles/md-anderson-research-highlights-special-edition-2024-world-conference-on-lung-cancer/?sc=rsin /articles/md-anderson-research-highlights-special-edition-2024-world-conference-on-lung-cancer/?sc=rsin Mon, 09 Sep 2024 14:05:55 EST The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. This special edition features compelling data on lung cancer advances presented by MD Anderson researchers at the 2024 World Conference on Lung Cancer. University of Texas MD Anderson Cancer Center /articles/md-anderson-research-highlights-for-september-4-2024/?sc=rsin /articles/md-anderson-research-highlights-for-september-4-2024/?sc=rsin Wed, 04 Sep 2024 12:00:56 EST The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson's world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. University of Texas MD Anderson Cancer Center /articles/americans-face-disparities-in-exposure-to-tobacco-on-streaming-platforms/?sc=rsin /articles/americans-face-disparities-in-exposure-to-tobacco-on-streaming-platforms/?sc=rsin Thu, 22 Aug 2024 11:00:00 EST Tens of millions of Americans are being exposed to tobacco content on streaming services, according to new research from The University of Texas MD Anderson Cancer Center. University of Texas MD Anderson Cancer Center /articles/md-anderson-receives-over-21-4-million-in-cprit-funding-to-support-research-and-launch-new-core-facilities/?sc=rsin /articles/md-anderson-receives-over-21-4-million-in-cprit-funding-to-support-research-and-launch-new-core-facilities/?sc=rsin Wed, 21 Aug 2024 18:00:57 EST The University of Texas MD Anderson Cancer Center today was awarded nine grants totaling over $21.4 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of two new core facilities, faculty recruitment and groundbreaking cancer research across all areas of the institution. University of Texas MD Anderson Cancer Center /articles/md-anderson-research-highlights-for-august-21-2024/?sc=rsin /articles/md-anderson-research-highlights-for-august-21-2024/?sc=rsin Wed, 21 Aug 2024 12:00:44 EST The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson's world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. University of Texas MD Anderson Cancer Center /articles/nk-cells-expressing-interleukin-21-show-promising-antitumor-activity-in-glioblastoma-cells/?sc=rsin /articles/nk-cells-expressing-interleukin-21-show-promising-antitumor-activity-in-glioblastoma-cells/?sc=rsin Mon, 12 Aug 2024 11:00:00 EST Natural killer (NK) cells engineered to express interleukin-21 (IL-21) demonstrated sustained antitumor activity against glioblastoma stem cell-like cells (GSCs) both in vitro and in vivo, according to new research from The University of Texas MD Anderson Cancer Center. University of Texas MD Anderson Cancer Center /articles/md-anderson-recognizes-outstanding-faculty/?sc=rsin /articles/md-anderson-recognizes-outstanding-faculty/?sc=rsin Fri, 09 Aug 2024 09:05:42 EST The University of Texas MD Anderson Cancer Center last night recognized over 100 faculty members at its annual Celebration of Faculty Excellence awards ceremony, acknowledging their compassionate care, exceptional contributions to their fields and the distinction they have brought to the institution. University of Texas MD Anderson Cancer Center /articles/md-anderson-research-highlights-for-august-7-2024/?sc=rsin /articles/md-anderson-research-highlights-for-august-7-2024/?sc=rsin Wed, 07 Aug 2024 12:00:40 EST The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson's world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments at MD Anderson include insights into evolutionary cellular adaptations to environmental stressors, potential targets to overcome trouble swallowing in head and neck cancer patients treated with radiation therapy, a promising chemotherapy-free combination treatment for patients with a subset of acute lymphocytic leukemia, a single-cell atlas for stomach cancer metastasis, encouraging results of a PARP inhibitor on patients with advanced cancers and specific DNA damage repair mutations, and a liquid biopsy signature that could improve early pancreatic cancer detection. University of Texas MD Anderson Cancer Center /articles/adding-metastasis-directed-radiation-therapy-boosts-progression-free-survival-in-metastatic-pancreatic-cancer/?sc=rsin /articles/adding-metastasis-directed-radiation-therapy-boosts-progression-free-survival-in-metastatic-pancreatic-cancer/?sc=rsin Mon, 05 Aug 2024 16:00:00 EST Researchers from The University of Texas MD Anderson Cancer Center demonstrated that adding metastasis-directed radiation therapy to standard-of-care chemotherapy improved progression-free survival (PFS) in patients with oligometastatic pancreatic cancer. University of Texas MD Anderson Cancer Center /articles/md-anderson-and-collaborators-to-launch-project-studying-t-cells-on-international-space-station/?sc=rsin /articles/md-anderson-and-collaborators-to-launch-project-studying-t-cells-on-international-space-station/?sc=rsin Wed, 31 Jul 2024 09:00:48 EST The University of Texas MD Anderson Cancer Center and collaborators are initiating a research project that will send T cells to the International Space Station (ISS) to study the effects of prolonged microgravity on cell differentiation, activation, memory and exhaustion. University of Texas MD Anderson Cancer Center /articles/md-anderson-and-summit-therapeutics-announce-strategic-collaboration-to-accelerate-development-of-ivonescimab/?sc=rsin /articles/md-anderson-and-summit-therapeutics-announce-strategic-collaboration-to-accelerate-development-of-ivonescimab/?sc=rsin Thu, 25 Jul 2024 08:00:12 EST MD Anderson and Summit Therapeutics announced a strategic five-year collaboration to accelerate the development of ivonescimab, a novel PD-1/VEGF bispecific antibody. University of Texas MD Anderson Cancer Center /articles/md-anderson-research-highlights-for-july-24-2024/?sc=rsin /articles/md-anderson-research-highlights-for-july-24-2024/?sc=rsin Wed, 24 Jul 2024 12:00:27 EST The University of Texas MD Anderson Cancer Center's Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson's world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. University of Texas MD Anderson Cancer Center /articles/md-anderson-ranked-no-1-in-the-nation-for-cancer-care/?sc=rsin /articles/md-anderson-ranked-no-1-in-the-nation-for-cancer-care/?sc=rsin Tue, 16 Jul 2024 00:05:39 EST The University of Texas MD Anderson Cancer Center today was ranked number one in the nation for cancer care in U.S. News & World Report's 2024-25 "Best Hospitals" survey. Since the survey's inception in 1990, MD Anderson has consistently been one of the top two hospitals in the nation for cancer care, and it has maintained the top ranking for the past 10 years. University of Texas MD Anderson Cancer Center /articles/md-anderson-research-highlights-for-july-11-2024/?sc=rsin /articles/md-anderson-research-highlights-for-july-11-2024/?sc=rsin Thu, 11 Jul 2024 12:00:14 EST The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Anderson experts. These advances are made possible through seamless collaboration between MD Anderson's world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. University of Texas MD Anderson Cancer Center /articles/study-supports-precision-radiation-therapy-in-lung-cancer/?sc=rsin /articles/study-supports-precision-radiation-therapy-in-lung-cancer/?sc=rsin Thu, 27 Jun 2024 11:00:00 EST Results from a new study led by researchers at The University of Texas MD Anderson Cancer Center support standard use of the more precise intensity-modulated radiotherapy (IMRT) over the alternative 3D-conformal radiotherapy (3D-CRT) for patients with unresectable, locally advanced non-small cell lung cancer (NSCLC). University of Texas MD Anderson Cancer Center /articles/md-anderson-and-rice-launch-cancer-bioengineering-collaborative/?sc=rsin /articles/md-anderson-and-rice-launch-cancer-bioengineering-collaborative/?sc=rsin Thu, 27 Jun 2024 10:00:30 EST MD Anderson and Rice announced the creation of the Cancer Bioengineering Collaborative to develop innovative technologies and bioengineering approaches to improve cancer research, diagnosis and treatment. University of Texas MD Anderson Cancer Center /articles/activating-molecular-target-reverses-multiple-hallmarks-of-aging/?sc=rsin /articles/activating-molecular-target-reverses-multiple-hallmarks-of-aging/?sc=rsin Fri, 21 Jun 2024 11:00:00 EST Researchers at The University of Texas MD Anderson Cancer Center have demonstrated that therapeutically restoring 'youthful' levels of a specific subunit of the telomerase enzyme can significantly reduce the signs and symptoms of aging in preclinical models. If these findings are confirmed in clinical studies, there may be therapeutic implications for age-related diseases such as Alzheimer's, Parkinson's, heart disease and cancer. University of Texas MD Anderson Cancer Center